MannKind Corp reports results for the quarter ended in June - Earnings Summary

MannKind

07/08/2024 14:32

* MannKind Corp  MNKD.OQ  reported a quarterly adjusted loss
of 1
cent​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -2
cents.  The mean expectation of four analysts for the quarter
was for earnings of one cent per share. Wall Street expected
results to range from zero cents to 2 cents per share.
    * Revenue rose 48.9% to $72.39 million from a year ago;
analysts
expected $64.81 million. 
    * MannKind Corp's reported EPS for the quarter was a loss of
1
cent​.
    * The company reported a quarterly loss of $2.01 million.
    * MannKind Corp shares had risen by 1.0% this quarter and
gained 44.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MannKind Corp is
$6.50 
This summary was machine generated from LSEG data August 7 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.01           -0.01          Missed
 Mar. 31 2024      0.03           0.04           Beat
 Dec. 31 2023      0.00           0.00           Met
 Sep. 30 2023      -0.02          0.01           Beat